Non-hematopoietic EPO analog that activates the innate repair receptor (IRR) to reduce inflammation and protect tissue.
For athletes, the primary value of ARA-290 lies in its ability to tissue protection, neuropathy relief, and anti-inflammatory action.. This mechanism is particularly relevant during high-volume training phases when tissue repair demand exceeds the body's natural recovery capacity.
Variable — onset typically within 2–8 weeks depending on protocol and individual response.
Individual response varies based on injury severity, training load, and baseline health markers.
Favorable safety profile in Phase II trials. Does not stimulate erythropoiesis.
Always verify current WADA status with your sport's governing body before use in competition.
https://pubmed.ncbi.nlm.nih.gov/25246403/
https://pubmed.ncbi.nlm.nih.gov/26296072/
Start a ARA-290 Protocol
Hatter Labs provides physician-supervised performance protocols with GMP-certified ARA-290 and comprehensive biomarker monitoring.
Get ProtocolCompare & Stack
Start Your Performance Protocol for ARA-290
Hatter Labs provides physician-supervised performance protocols with GMP-certified compounds, biomarker testing, and personalized programs designed around your training goals.
HIPAA Compliant · GMP Certified · Physician Supervised